Clinical Trial Update: Neoadjuvant PD-1 Inhibitor Combined With Cetuximab and Platinum in Resectable Locally Advanced Hypopharyngeal Carcinoma [Phase 2]

View source ↗

Summary

A Phase 2 neoadjuvant trial evaluating a PD-1 inhibitor with cetuximab and platinum for resectable locally advanced hypopharyngeal cancer is currently recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypopharyngeal Cancer

Drugs mentioned

• Cetuximab (cetuximab)
• PD-1 inhibitor
• Platinum-based chemotherapy (platinum-based chemotherapy)

Snippet

Sponsor: Eye & ENT Hospital of Fudan University | Conditions: Locally Advanced Hypopharyngeal Carcinoma | Phase 2 | Status: RECRUITING